Kidney Cancer Treatment Market By Treatment, By Class of drugs, By Distribution Channel and Geography

Kidney Cancer Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Treatment (Targeted Therapy, Immunotherapy, Radiation Therapy, Neurosurgical Treatments (Cryoablation, Radiofrequency ablation), By Class of drugs (mTOR Inhibitors, Angiogenesis Inhibitors, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region

Kidney Cancer Treatment Market size was valued at US$ 6,332.8 million in 2023 and is poised to grow at a CAGR of 6.6% during 2024-2030. The kidney cancer treatment market refers to the market for developing therapeutics and treatment options specifically targeted at kidney cancer, also known as renal cell carcinoma (RCC). Kidney cancer is a type of cancer that originates in the kidneys, which are responsible for filtering waste from the blood and producing urine. It is a kind of cancer that is rather prevalent, with regional variations in incidence rates. The kidney cancer treatment market encompasses a broad variety of treatment modalities, including surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and combination therapies. These therapies aim to stop or at least limit the proliferation of cancer cells, stop the disease from spreading, and enhance the patient’s quality of life. The kidney cancer treatment market is primarily driven by the increasing incidence and prevalence of kidney cancer worldwide.

According to the World Cancer Research Journal, kidney cancer causes 144,000 deaths and 338,000 new cases worldwide each year. Other factors that support the expansion of the kidney cancer treatment market include improvements in diagnostic procedures like computed tomography (CT) scans and magnetic resonance imaging (MRI), the creation of novel and targeted therapies like tyrosine kinase inhibitors and immune checkpoint inhibitors, and increase in research and development activities. Moreover, development of immunotherapy in kidney cancer treatment, adoption of minimally invasive surgical techniques and biomarker-based diagnosis and treatment crate favourable environment for the growth of the kidney cancer treatment market in the forecasting years.

However, expensive kidney cancer treatment, especially when considering the cost of surgeries, targeted therapies, immunotherapies, and follow-up care can limit the access to advanced treatment options for some patients in regions with limited healthcare resources impede the kidney cancer treatment market. Various pharmaceutical companies are introducing innovative treatment options and advancements in medical technology to further contribute to market growth. For instance, in November 2021, Merck’s KEYTRUDA (pembrolizumab) got FDA approval as adjuvant therapy for patients with renal cell carcinoma (RCC) following surgery.

Kidney Cancer Treatment Market Key Developments:

  • In October 2021, Biocon announced the launch of Everolimus tablets, a generic version of Afinitor, in the US.
  • In March 2021, the FDA approved AVEO Oncology’s FOTIVDA for the treatment of adults with relapsed or refractory advanced renal cell carcinoma (RCC).

Kidney Cancer Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Kidney Cancer Treatment Market Dynamics

kidney cancer treatment market is expected to grow at significant rates owing to the factors such as increase in prevalence of kidney cancer due to the lifestyle changes and increase in smoking and consuming alcohol. In addition, increase in geriatric population who are more prone to the kidney related diseases coupled with the increase in R&D support and investments by the government in screening of cancer and in development of new treatment of drugs. Furthermore, availability of kidney cancer treating drugs are low, it is likely to act as growth opportunity for development of new drug treatments for the treatment. However, high prices of available branded drugs for the treatment of kidney cancer and high R&D expenditure for the development of new drugs are expected to hinder the market growth over the forecast period.

Kidney Cancer Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 6,332.8 million

Market CAGR

6.6%

By Treatment

  • Targeted Therapy
  • Immunotherapy
  • Radiation Therapy
  • Neurosurgical Treatments
    • Cryoablation
    • Radiofrequency ablation

By Drug Class

  • mTOR Inhibitors
  • Angiogenesis Inhibitors
  • Monoclonal Antibodies
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa.

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup's details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

The global kidney cancer treatment market size was valued at US$ 6,332.8 million in 2023 and is expected to grow at a CAGR of 6.6% from 2024 to 2030.

The kidney cancer treatment market key players are Abbott Laboratories, Amgen Inc., Bayer AG, Bristol-Myers Squibb, F. Hoffmann-La Roche, Merck KGaA (EMD Serono), Novartis International AG

Asia Pacific is the fastest-growing region in the kidney cancer treatment market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

  1. Executive Summary
  2. Global Kidney Cancer Treatment Market Introduction
    • Global Kidney Cancer Treatment Market - Taxonomy
    • Global Kidney Cancer Treatment Market -Definitions
      • Treatment
      • Class of Drugs
      • Distribution Channel
  3. Global Kidney Cancer Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Kidney Cancer Treatment Market Dynamic Factors - Impact Analysis
    • Global Kidney Cancer Treatment Market - Competition Landscape
    • Epidemiology
  4. Global Kidney Cancer Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
    • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  5. Global Kidney Cancer Treatment Market, By Treatment, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Targeted Therapy
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Immunotherapy
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Radiation Therapy
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Neurosurgical Treatments
      • Cryoablation
        • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Radiofrequency ablation
        • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
  1. Global Kidney Cancer Treatment Market Forecast, By Class of Drugs, 2019 - 2023 and Forecast, 2024 - 2030
    • mTOR Inhibitors
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Angiogenesis Inhibitors
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Monoclonal Antibodies
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Kidney Cancer Treatment Market Forecast, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Kidney Cancer Treatment Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Region, 2024 - 2030
  2. North America Kidney Cancer Treatment Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis 2016 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • S.
        • Canada
      • North America Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country, 2024 - 2030
      • North America Kidney Cancer Treatment Market Dynamics - Trends
  1. Europe Kidney Cancer Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country,2024 - 2030
      • Europe Kidney Cancer Treatment Market Dynamics - Trends
  1. Asia-Pacific Kidney Cancer Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Japan
        • China
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of Asia-Pacific
      • Asia-Pacific Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country,2024 - 2030
      • Asia-Pacific Kidney Cancer Treatment Market Dynamics - Trends
  1. Latin America Kidney Cancer Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Venezuela
        • Rest of Latin America
      • Latin America Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country,2024 - 2030
      • Latin America Kidney Cancer Treatment Market Dynamics - Trends
  1. Middle East and Africa Kidney Cancer Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country,2024 - 2030
      • MEA Kidney Cancer Treatment Market Dynamics - Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Treatment& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Pfizer Inc. (U.S.)
      • GlaxoSmithKline Plc. (U.K.)
      • Bayer AG (Germany)
      • Novartis AG (Switzerland)
      • Hoffman-La Roche (Switzerland)
      • EUSA Pharma (U.K.)
      • BTG plc (U.K.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Key Market Players

  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline Plc. (U.K.)
  • Bayer AG (Germany)
  • Novartis AG (Switzerland)
  • Hoffman-La Roche (Switzerland)
  • EUSA Pharma (U.K.)
  • BTG plc (U.K.)

Related Industry Reports